随着药品不良反应监测报告工作的深入开展,尤其是“齐二药事件”和安徽“华源药业”等药害事件的发生,给卫生界尤其是药学界工作带来了极大震动。医院如何保证用药安全、杜绝假劣药、推进合理用药、减少不良反应的发生、确保临床疗效,既是临床医生的重要课题,也是药剂人员面临? With the advent of monitoring reports on adverse drug reactions, especially the occurrence of phytosanitary events such as the “Qi Er Yi Incident” and Anhui “Huayuan Pharmaceutical”, this has brought tremendous shock to the work of the health profession, especially the pharmaceutical industry. How to ensure the safety of medication in hospitals, to eliminate counterfeit drugs, to promote rational use of drugs to reduce the incidence of adverse reactions to ensure clinical efficacy, is an important issue for clinicians, but also pharmacy staff face?